{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:25:07Z","timestamp":1794565507698,"version":"4.9.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Comparative Pathology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jcpa.2026.08.006","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:14:40Z","timestamp":1789661680000},"page":"25-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Immunohistochemical investigation of the stem cell landscape of canine prostate cancer"],"prefix":"10.1016","volume":"230","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8084-5446","authenticated-orcid":false,"given":"Michelle M.","family":"Story","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6702-6139","authenticated-orcid":false,"given":"Carlos E.","family":"Fonseca-Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8653-7938","authenticated-orcid":false,"given":"Renee","family":"Laufer-Amorim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcpa.2026.08.006_bib1","article-title":"Prostate cancer incidence and mortality: global status and temporal trends in 89 countries from 2000 to 2019","volume":"10","author":"Wang","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.jcpa.2026.08.006_bib2","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1038\/onc.2013.206","article-title":"Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches","volume":"32","author":"Karantanos","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.jcpa.2026.08.006_bib3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ncpuro1296","article-title":"Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion","volume":"6","author":"Harris","year":"2009","journal-title":"Nat Clin Pract Urol"},{"key":"10.1016\/j.jcpa.2026.08.006_bib4","doi-asserted-by":"crossref","first-page":"10946","DOI":"10.1158\/0008-5472.CAN-05-2018","article-title":"Prospective identification of tumorigenic prostate cancer stem cells","volume":"65","author":"Collins","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcpa.2026.08.006_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188887","article-title":"Cancer stem cell in prostate cancer progression, metastasis and therapy resistance","volume":"1878","author":"Verma","year":"2023","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.jcpa.2026.08.006_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.biocel.2019.01.002","article-title":"Characterization of OCT3\/4, nestin, NANOG, CD44 and CD24 as stem cell markers in canine prostate cancer","volume":"108","author":"Costa","year":"2019","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jcpa.2026.08.006_bib7","first-page":"1917","article-title":"Comparative characterization of stem cell marker expression, metabolic activity and resistance to doxorubicin in adherent and spheroid cells derived from the canine prostate adenocarcinoma cell line CT1258","volume":"35","author":"Liu","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jcpa.2026.08.006_bib8","first-page":"5421","article-title":"Evaluation of stem cell marker gene expression in canine prostate carcinoma- and prostate cyst-derived cell lines","volume":"33","author":"Moulay","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jcpa.2026.08.006_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2022.881232","article-title":"A review on canine and feline prostate pathology","volume":"9","author":"Palmieri","year":"2022","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.jcpa.2026.08.006_bib10","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/sj.onc.1209327","article-title":"Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells","volume":"25","author":"Patrawala","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.jcpa.2026.08.006_bib11","doi-asserted-by":"crossref","first-page":"763","DOI":"10.4161\/cbt.6.5.3996","article-title":"Cancer stem-like cells in human prostate carcinoma cells DU145: the seeds of the cell line?","volume":"6","author":"Wei","year":"2007","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.jcpa.2026.08.006_bib12","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1038\/onc.2011.114","article-title":"NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation","volume":"30","author":"Jeter","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.jcpa.2026.08.006_bib13","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1158\/0008-5472.CAN-06-4608","article-title":"Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo","volume":"67","author":"Gu","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcpa.2026.08.006_bib14","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1016\/j.cellsig.2013.08.041","article-title":"SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells","volume":"25","author":"Rybak","year":"2013","journal-title":"Cell Signal"},{"key":"10.1016\/j.jcpa.2026.08.006_bib15","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.3390\/cancers11091331","article-title":"Elimination of SOX2\/OCT4-associated prostate cancer stem cells blocks tumor development and enhances therapeutic response","volume":"11","author":"Vaddi","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.jcpa.2026.08.006_bib16","doi-asserted-by":"crossref","unstructured":"Xie J, M\u00f8lck C, Paquet-Fifield S, Butler L; Australian Prostate Cancer Bioresource; Sloan E, et al. High expression of TROP2 characterizes different cell subpopulations in androgen-sensitive and androgen-independent prostate cancer cells. Oncotarget 2016;7:44492\u201344504. http:\/\/doi.org\/10.18632\/oncotarget.9876.","DOI":"10.18632\/oncotarget.9876"},{"key":"10.1016\/j.jcpa.2026.08.006_bib17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jcpa.2019.07.005","article-title":"Histopathological terminology standards for the reporting of prostatic epithelial lesions in dogs","volume":"171","author":"Palmieri","year":"2019","journal-title":"J Comp Pathol"},{"key":"10.1016\/j.jcpa.2026.08.006_bib18","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/stem.29","article-title":"Functional evidence that the self-renewal gene NANOG regulates human tumor development","volume":"27","author":"Jeter","year":"2009","journal-title":"Stem Cell"},{"key":"10.1016\/j.jcpa.2026.08.006_bib19","doi-asserted-by":"crossref","first-page":"9199","DOI":"10.1158\/0008-5472.CAN-07-0806","article-title":"Roles for the stem cell associated intermediate filament Nestin in prostate cancer migration and metastasis","volume":"67","author":"Kleeberger","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcpa.2026.08.006_bib20","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s13277-011-0162-9","article-title":"Analysis of nuclear nestin localization in cell lines derived from neurogenic tumors","volume":"32","author":"Krupkova","year":"2011","journal-title":"Tumour Biol"},{"key":"10.1016\/j.jcpa.2026.08.006_bib21","first-page":"73","article-title":"The role of Trop2 in prostate cancer: an oncogene, biomarker, and therapeutic target","volume":"9","author":"Shen","year":"2021","journal-title":"Am J Clin Exp Urol"},{"key":"10.1016\/j.jcpa.2026.08.006_bib22","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1091\/mbc.e02-08-0545","article-title":"Nestin promotes the phosphorylation-dependent disassembly of vimentin intermediate filaments during mitosis","volume":"14","author":"Chou","year":"2003","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.jcpa.2026.08.006_bib23","doi-asserted-by":"crossref","first-page":"16456","DOI":"10.1074\/jbc.M009669200","article-title":"Mitotic reorganization of the intermediate filament protein nestin involves phosphorylation by cdc2 kinase","volume":"276","author":"Sahlgren","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcpa.2026.08.006_bib24","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1038\/sj.emboj.7601366","article-title":"A nestin scaffold links Cdk5\/p35 signaling to oxidant-induced cell death","volume":"25","author":"Sahlgren","year":"2006","journal-title":"EMBO J"},{"key":"10.1016\/j.jcpa.2026.08.006_bib25","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3892\/ol.2014.2274","article-title":"Immunohistochemical expression of four different stem cell markers in prostate cancer: high expression of NANOG in conjunction with hypoxia-inducible factor-1\u03b1 expression is involved in prostate epithelial malignancy","volume":"8","author":"Miyazawa","year":"2014","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jcpa.2026.08.006_bib26","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/bjc.2011.270","article-title":"Specific detection of OCT3\/4 isoform A\/B\/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3\/4 specificity for germ cell tumours","volume":"105","author":"Rijlaarsdam","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jcpa.2026.08.006_bib27","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1634\/stemcells.2005-0611","article-title":"POU5F1 isoforms show different expression patterns in human embryonic stem cells and preimplantation embryos","volume":"24","author":"Cauffman","year":"2006","journal-title":"Stem Cell"},{"key":"10.1016\/j.jcpa.2026.08.006_bib28","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1634\/stemcells.2008-0530","article-title":"OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells","volume":"26","author":"Atlasi","year":"2008","journal-title":"Stem Cell"},{"key":"10.1016\/j.jcpa.2026.08.006_bib29","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/pros.20895","article-title":"Oct4A is expressed by a subpopulation of prostate neuroendocrine cells","volume":"69","author":"Sotomayor","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.jcpa.2026.08.006_bib30","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/ijc.22508","article-title":"OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer","volume":"120","author":"Atlasi","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jcpa.2026.08.006_bib31","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/jclinpath-2017-204815","article-title":"Subcellular localisation of the stem cell markers OCT4, SOX2, NANOG, KLF4 and c-MYC in cancer: a review","volume":"71","author":"van Schaijik","year":"2018","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jcpa.2026.08.006_bib32","doi-asserted-by":"crossref","first-page":"43540","DOI":"10.18632\/oncotarget.6183","article-title":"Molecular and functional interactions between AKT and SOX2 in breast carcinoma","volume":"6","author":"Schaefer","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jcpa.2026.08.006_bib33","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa2028485","article-title":"Sacituzumab govitecan in metastatic triple-negative breast cancer","volume":"384","author":"Bardi","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcpa.2026.08.006_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7320","article-title":"Preclinical evidence for the use of anti-Trop-2 antibody-drug conjugate sacituzumab govitecan in cerebral metastasized castration-resistant prostate cancer","volume":"13","author":"Weiten","year":"2024","journal-title":"Cancer Med"},{"key":"10.1016\/j.jcpa.2026.08.006_bib35","first-page":"1","article-title":"Emerging antibody-drug conjugates in metastatic castration-resistant prostate cancer","author":"Nguyen","year":"2026","journal-title":"Urol Oncol Semin Orig Investig"}],"container-title":["Journal of Comparative Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021997526001088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021997526001088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:48:01Z","timestamp":1794563281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021997526001088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":35,"alternative-id":["S0021997526001088"],"URL":"https:\/\/doi.org\/10.1016\/j.jcpa.2026.08.006","relation":{},"ISSN":["0021-9975"],"issn-type":[{"value":"0021-9975","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunohistochemical investigation of the stem cell landscape of canine prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Comparative Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcpa.2026.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}